Developer docs
API playgroundTry for free, no card

Search company profiles

Biotek Remedys

Full company profile

uuid000iu76

Namestring
Biotek Remedys
Legal namestring
BioTek reMEDys
Websiteurl
biotekrx.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

BioTek reMEDys is a US-based specialty pharmacy founded in 2013 that dispenses specialty medications, biologics, and infusion therapies to patients with rare diseases and chronic conditions. Its therapeutic focus spans primary immunodeficiency (IVIG and SCIG therapy), bleeding disorders (factor therapy for hemophilia A, B, C and von Willebrand disease), multiple sclerosis, hepatitis, post-transplant care, and Huntington's disease. The company operates as an integrated infusion therapy provider, bridging managed care organizations, prescribing physicians, and patients through supply chain management, prior authorization handling, specialty drug dispensing, home infusion coordination, and clinical support services.

The technology platform consists of an integrated web portal for end-to-end order tracking, a patient-facing web portal with auto-refill functionality, and a 24/7 National Customer Support Center staffed by clinical personnel including a pharmacist on call. BioTek holds URAC Specialty Pharmacy Accreditation (ID SPP006999, valid through March 1, 2029) and is recognized by the Immunoglobulin Nursing Society (IgNS). It maintains partnerships with the Hemophilia Federation of America, Hemophilia Treatment Centers, manufacturer patient assistance programs, and a nationwide network of home infusion nurses. Physical operations are centered at a New Castle, Delaware headquarters (which also houses an on-site infusion suite) and a Houston, Texas regional office branded Biotek South.

Revenue is generated primarily through reimbursement from managed care organizations, Medicare, Medicaid, and commercial insurance plans for dispensed specialty medications and home infusion services. The go-to-market model is hybrid B2B2C: a sales-led motion driven by physician and prescriber referrals (accepted electronically, by fax, or phone) combined with direct-to-consumer engagement via the voluntary Patient Management Program, a 24/7 helpline, and patient education content including the Carol's Corner blog. The company employs 51-100 staff and serves patients across all US geographies through free scheduled home or clinic delivery.

Short descriptiontext

BioTek reMEDys is a US specialty pharmacy founded in 2013 that dispenses infusion and specialty medications (IVIG/SCIG, factor therapy, MS, hepatitis, transplant, Huntington's) to patients with rare and chronic conditions, coordinating with physicians, payors, and home infusion nurses nationwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew Castle, United States
HQ citystring
New Castle
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmacy services, infusion therapy management, rare disease medications, home infusion nursing, bleeding disorder treatment
Industry2 codes
PRIMARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLAIAJAH
Biologics & Biosimilars Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SIC code1 code
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Specialty Pharmacy Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Specialty Pharmacy Services
TypeManaged Services
Description

BioTek reMEDys operates as a specialty pharmacy providing high-end specialty pharmaceutical products. They manage drug utilization, coordinate with physicians and manufacturers, and deliver just-in-time pharmacy distribution services. Revenue is generated through reimbursement from managed care organizations, Medicare, and commercial insurance plans for specialty medications and infusion services.

biotekrx.com
2Bleeding Disorder Program Services
TypeManaged Services
Description

Specialized programs for hemophilia, von Willebrand disease, and other factor deficiencies. Services include PICC & IV access management, joint bleed assessments, patient education, and coordination with hemophilia treatment centers. Covered by Medicare Medical Assistance and major commercial insurance plans.

biotekrx.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

BioTek reMEDys is a specialty pharmacy providing integrated infusion therapy and specialty medications for patients with rare diseases and chronic conditions. The company delivers IVIG and SCIG immunoglobulin therapy, factor therapy for bleeding disorders, home infusion nursing services, and disease-specific care programs for hepatitis, multiple sclerosis, transplants, and Huntington's disease. It bridges managed care, physicians, and patients through supply chain management, specialty-trained pharmacists, and an integrated web portal for order tracking.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Delivers superior service at a lower cost through supply chain management and technology
+2 more records
Product overview1 text field

BioTek reMEDys is a specialty pharmacy providing integrated infusion therapy services for patients with rare diseases and chronic conditions. The company operates as a unified specialty pharmacy platform offering IVIG and SCIG immunoglobulin therapies, factor therapy for bleeding disorders, and disease-specific specialty care programs for Hepatitis, Transplants, Multiple Sclerosis, and Huntington's Disease. Services include home infusion delivery, their Patient Management Program (PMP), and an on-site infusion suite. The company bridges managed care, physicians, and patients through supply chain management, specialty pharmacists, and trained infusion nurses.

Product and service12 records
1IVIG (Intravenous Immunoglobulin) Therapy
CategoryCore therapy service
2SCIG (Subcutaneous Immunoglobulin) Therapy
CategoryCore therapy service
3Factor Therapy
CategoryCore therapy service
4Bleeding Disorders Program
CategorySpecialty care program
5Patient Management Program (PMP)
CategoryCare management service
6Specialty Pharmacy Services
CategoryCore service
7Home Infusion Services
CategoryCare delivery service
8Hepatitis Management
CategorySpecialty care program
9Transplant Support
CategorySpecialty care program
10Multiple Sclerosis Management
CategorySpecialty care program
11Huntington's Disease Management
CategorySpecialty care program
12Infusion Suite
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1Hemophilia Federation of America (HFA)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

BioTek reMEDys has partnered with the Hemophilia Federation of America to administer three $1,000 scholarships for individuals impacted by hemophilia or other significant bleeding disorders. Applications are submitted directly to HFA, and BioTek staff do not see applications or have input into the selection process, ensuring impartiality.

biotekrx.com
Strategic tierCoreTypeOthers
Description

URAC provides independent accreditation for BioTek reMEDys specialty pharmacy operations, validating compliance with quality standards for pharmacy benefit management and clinical operations.

Strategic tierMinorTypeOthers
Description

IgNS logo appears on the company website indicating membership or recognition from the Immunoglobulin Nursing Society, representing nurses specialized in immunoglobulin therapy.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

BioTek reMEDys coordinates with extensive nurses and nursing networks to deliver experienced infusion nurses in any area of the country. These partnerships enable home infusion services that offer lower cost and convenience compared to hospital-based infusion.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Company helps patients navigate Manufacturer Assistance Programs and foundations to access medications and reduce out-of-pocket costs. They coordinate access to patient assistance programs for those who qualify.

6Hemophilia Treatment Centers
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

BioTek reMEDys maintains active communication and care coordination with Hemophilia Treatment Centers (HTCs) and healthcare providers to optimize patient outcomes and ensure comprehensive care for bleeding disorder patients.

biotekrx.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest US specialty pharmacy, owned by Evernorth (Cigna). Provides specialty medication dispensing, infusion services, and care management programs across rare and chronic conditions — directly comparable to BioTek's offerings.

TypeDirect peer
Description

Specialty pharmacy exclusively focused on rare and orphan diseases, providing high-touch dispensing, patient management, and manufacturer distribution services — closest niche competitor to BioTek's rare-disease focus.

TypeDirect peer
Description

Specialty pharmacy arm of UnitedHealth/Optum, serving patients with complex conditions including hemophilia and immune disorders with national distribution and clinical management — direct competitor.

TypeBroad incumbent
Description

Specialty pharmacy arm of CVS Health, offering nationwide specialty medication fulfillment and clinical support integrated with Caremark PBM — broader incumbent with overlapping service lines.

TypeBroad incumbent
Description

Specialty pharmacy services within Walgreens, providing nationwide specialty drug fulfillment and patient support programs integrated with retail footprint — broad incumbent in the same market.

TypeDirect peer
Description

Specialty pharmacy owned by Cencora (formerly AmerisourceBergen), distributing specialty medications and providing patient management programs across therapeutic categories — directly comparable specialty pharmacy.

TypeDirect peer
Description

Specialty infusion provider delivering home and alternate-site infusion therapies including IVIG and biologics — directly comparable to BioTek's home infusion and immunoglobulin therapy services.

TypeDirect peer
Description

Specialty infusion pharmacy focused on hemophilia, immune disorders, and rare conditions, providing home infusion nursing and specialty drug distribution — directly comparable mid-size specialty pharmacy.

TypeDirect peer
Description

Independent specialty pharmacy providing specialty medications, infusion services, and clinical management for chronic and rare conditions — comparable independent specialty pharmacy competitor.

TypeDirect peer
Description

Specialty pharmacy and pharmacy benefit manager owned by a consortium of Blue Cross Blue Shield plans, providing specialty drug distribution and care management — comparable specialty pharmacy peer with payor-aligned business model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biotek Remedys

Specialty Pharmacy Servicesbiotekrx.com

BioTek reMEDys is a US specialty pharmacy founded in 2013 that dispenses infusion and specialty medications (IVIG/SCIG, factor therapy, MS, hepatitis, transplant, Huntington's) to patients with rare and chronic conditions, coordinating with physicians, payors, and home infusion nurses nationwide.

What Biotek Remedys does

BioTek reMEDys is a US-based specialty pharmacy founded in 2013 that dispenses specialty medications, biologics, and infusion therapies to patients with rare diseases and chronic conditions. Its therapeutic focus spans primary immunodeficiency (IVIG and SCIG therapy), bleeding disorders (factor therapy for hemophilia A, B, C and von Willebrand disease), multiple sclerosis, hepatitis, post-transplant care, and Huntington's disease. The company operates as an integrated infusion therapy provider, bridging managed care organizations, prescribing physicians, and patients through supply chain management, prior authorization handling, specialty drug dispensing, home infusion coordination, and clinical support services.

The technology platform consists of an integrated web portal for end-to-end order tracking, a patient-facing web portal with auto-refill functionality, and a 24/7 National Customer Support Center staffed by clinical personnel including a pharmacist on call. BioTek holds URAC Specialty Pharmacy Accreditation (ID SPP006999, valid through March 1, 2029) and is recognized by the Immunoglobulin Nursing Society (IgNS). It maintains partnerships with the Hemophilia Federation of America, Hemophilia Treatment Centers, manufacturer patient assistance programs, and a nationwide network of home infusion nurses. Physical operations are centered at a New Castle, Delaware headquarters (which also houses an on-site infusion suite) and a Houston, Texas regional office branded Biotek South.

Revenue is generated primarily through reimbursement from managed care organizations, Medicare, Medicaid, and commercial insurance plans for dispensed specialty medications and home infusion services. The go-to-market model is hybrid B2B2C: a sales-led motion driven by physician and prescriber referrals (accepted electronically, by fax, or phone) combined with direct-to-consumer engagement via the voluntary Patient Management Program, a 24/7 helpline, and patient education content including the Carol's Corner blog. The company employs 51-100 staff and serves patients across all US geographies through free scheduled home or clinic delivery.

Biotek Remedys firmographics

Firmographics
Name
Biotek Remedys
Legal name
BioTek reMEDys
Website
https://biotekrx.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
51–100 employees
Short description
BioTek reMEDys is a US specialty pharmacy founded in 2013 that dispenses infusion and specialty medications (IVIG/SCIG, factor therapy, MS, hepatitis, transplant, Huntington's) to patients with rare and chronic conditions, coordinating with physicians, payors, and home infusion nurses nationwide.
Ownership category
akta.pro rank

Biotek Remedys industry classification

Industry
Product category
Specialty Pharmacy Services
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLAIAJAH
Biologics & Biosimilars Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Specialty pharmacy services
  • Infusion therapy management
  • Rare disease medications
  • Home infusion nursing
  • Bleeding disorder treatment

Where Biotek Remedys is headquartered

Location

Headquarters

HQ city
New Castle
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Biotek Remedys business model

Business model
GTM type
B2B and B2C
Offering type
Services

Revenue model

  1. Specialty Pharmacy Services: BioTek reMEDys operates as a specialty pharmacy providing high-end specialty pharmaceutical products. They manage drug utilization, coordinate with physicians and manufacturers, and deliver just-in-time pharmacy distribution services. Revenue is generated through reimbursement from managed care organizations, Medicare, and commercial insurance plans for specialty medications and infusion services.
  2. Bleeding Disorder Program Services: Specialized programs for hemophilia, von Willebrand disease, and other factor deficiencies. Services include PICC & IV access management, joint bleed assessments, patient education, and coordination with hemophilia treatment centers. Covered by Medicare Medical Assistance and major commercial insurance plans.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Biotek Remedys product offering

Product offering

Core offering

BioTek reMEDys is a specialty pharmacy providing integrated infusion therapy and specialty medications for patients with rare diseases and chronic conditions. The company delivers IVIG and SCIG immunoglobulin therapy, factor therapy for bleeding disorders, home infusion nursing services, and disease-specific care programs for hepatitis, multiple sclerosis, transplants, and Huntington's disease. It bridges managed care, physicians, and patients through supply chain management, specialty-trained pharmacists, and an integrated web portal for order tracking.

Product overview

BioTek reMEDys is a specialty pharmacy providing integrated infusion therapy services for patients with rare diseases and chronic conditions. The company operates as a unified specialty pharmacy platform offering IVIG and SCIG immunoglobulin therapies, factor therapy for bleeding disorders, and disease-specific specialty care programs for Hepatitis, Transplants, Multiple Sclerosis, and Huntington's Disease. Services include home infusion delivery, their Patient Management Program (PMP), and an on-site infusion suite. The company bridges managed care, physicians, and patients through supply chain management, specialty pharmacists, and trained infusion nurses.

Differentiator

Problem solved

Functional benefit

Products and services

  • IVIG (Intravenous Immunoglobulin) Therapy
  • SCIG (Subcutaneous Immunoglobulin) Therapy
  • Factor Therapy
  • Bleeding Disorders Program
  • Patient Management Program (PMP)
  • Specialty Pharmacy Services
  • Home Infusion Services
  • Hepatitis Management
  • Transplant Support
  • Multiple Sclerosis Management
  • Huntington's Disease Management
  • Infusion Suite

Quantifiable outcome

  • Delivers superior service at a lower cost through supply chain management and technology
  • +2 more outcomes

Companies that use Biotek Remedys

Customer profile

Named customers5 records

Segments6 records

Biotek Remedys technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Biotek Remedys partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Hemophilia Federation of America (HFA)coreStrategic or Co-development PartnerBioTek reMEDys has partnered with the Hemophilia Federation of America to administer three $1,000 scholarships for individuals impacted by hemophilia or other significant bleeding disorders. Applications are submitted directly to HFA, and BioTek staff do not see applications or have input into the selection process, ensuring impartiality.
  • URACcoreOthersURAC provides independent accreditation for BioTek reMEDys specialty pharmacy operations, validating compliance with quality standards for pharmacy benefit management and clinical operations.
  • IgNS (Immunoglobulin Nursing Society)minorOthersIgNS logo appears on the company website indicating membership or recognition from the Immunoglobulin Nursing Society, representing nurses specialized in immunoglobulin therapy.
  • Home Infusion Provider NetworkcoreChannel Partner/ Reseller/ DistributorBioTek reMEDys coordinates with extensive nurses and nursing networks to deliver experienced infusion nurses in any area of the country. These partnerships enable home infusion services that offer lower cost and convenience compared to hospital-based infusion.
  • Patient Assistance ProgramscoreStrategic or Co-development PartnerCompany helps patients navigate Manufacturer Assistance Programs and foundations to access medications and reduce out-of-pocket costs. They coordinate access to patient assistance programs for those who qualify.
  • Hemophilia Treatment CenterscoreImplementation/ SI/ Consulting PartnerBioTek reMEDys maintains active communication and care coordination with Hemophilia Treatment Centers (HTCs) and healthcare providers to optimize patient outcomes and ensure comprehensive care for bleeding disorder patients.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Biotek Remedys competitors and assessment

Company assessment

Direct peers

  • Accredo by Evernorth: Largest US specialty pharmacy, owned by Evernorth (Cigna). Provides specialty medication dispensing, infusion services, and care management programs across rare and chronic conditions — directly comparable to BioTek's offerings.
  • PANTHERx Rare Pharmacy: Specialty pharmacy exclusively focused on rare and orphan diseases, providing high-touch dispensing, patient management, and manufacturer distribution services — closest niche competitor to BioTek's rare-disease focus.
  • Optum Specialty Pharmacy (BriovaRx): Specialty pharmacy arm of UnitedHealth/Optum, serving patients with complex conditions including hemophilia and immune disorders with national distribution and clinical management — direct competitor.
  • US Bioservices (Cencora): Specialty pharmacy owned by Cencora (formerly AmerisourceBergen), distributing specialty medications and providing patient management programs across therapeutic categories — directly comparable specialty pharmacy.
  • Soleo Health: Specialty infusion provider delivering home and alternate-site infusion therapies including IVIG and biologics — directly comparable to BioTek's home infusion and immunoglobulin therapy services.
  • Nufactor: Specialty infusion pharmacy focused on hemophilia, immune disorders, and rare conditions, providing home infusion nursing and specialty drug distribution — directly comparable mid-size specialty pharmacy.
  • CareMed Specialty Pharmacy: Independent specialty pharmacy providing specialty medications, infusion services, and clinical management for chronic and rare conditions — comparable independent specialty pharmacy competitor.
  • Prime Therapeutics Specialty Pharmacy: Specialty pharmacy and pharmacy benefit manager owned by a consortium of Blue Cross Blue Shield plans, providing specialty drug distribution and care management — comparable specialty pharmacy peer with payor-aligned business model.

Broad incumbents

  • CVS Specialty: Specialty pharmacy arm of CVS Health, offering nationwide specialty medication fulfillment and clinical support integrated with Caremark PBM — broader incumbent with overlapping service lines.
  • Walgreens Specialty Pharmacy: Specialty pharmacy services within Walgreens, providing nationwide specialty drug fulfillment and patient support programs integrated with retail footprint — broad incumbent in the same market.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Biotek Remedys social profiles

Digital presence

Biotek Remedys compliance and trust

Trust signal

Compliance1 record

Biotek Remedys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biotek Remedys leadership team

Management profile

Number of profiles

Biotek Remedys funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biotek Remedys M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotek Remedys

What does Biotek Remedys do?

BioTek reMEDys is a specialty pharmacy providing integrated infusion therapy and specialty medications for patients with rare diseases and chronic conditions. The company delivers IVIG and SCIG immunoglobulin therapy, factor therapy for bleeding disorders, home infusion nursing services, and disease-specific care programs for hepatitis, multiple sclerosis, transplants, and Huntington's disease. It bridges managed care, physicians, and patients through supply chain management, specialty-trained pharmacists, and an integrated web portal for order tracking.

Is Biotek Remedys a public or private company?

Biotek Remedys is a private company. It is currently operating.

When was Biotek Remedys founded?

Biotek Remedys was founded in 2013. It employs 51 to 100 people.

Where is Biotek Remedys based?

Biotek Remedys is headquartered in New Castle, United States, in the North America region.

How does Biotek Remedys make money?

Two revenue lines are on record. Specialty Pharmacy Services are the primary driver. The others are bleeding Disorder Program Services.

Who are Biotek Remedys's main competitors?

Direct peers on record are Accredo by Evernorth, PANTHERx Rare Pharmacy, Optum Specialty Pharmacy (BriovaRx), US Bioservices (Cencora), Soleo Health, Nufactor, CareMed Specialty Pharmacy and Prime Therapeutics Specialty Pharmacy. Broad incumbents are CVS Specialty and Walgreens Specialty Pharmacy.

Does Biotek Remedys have an API?

No public API is recorded for Biotek Remedys.

What industry is Biotek Remedys in?

Biotek Remedys's product category is Specialty Pharmacy Services. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms, with a secondary code of HLAIAJAH, Biologics & Biosimilars Distributors. Its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals